Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.

Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K.

Neuroimage. 2008 Oct 1;42(4):1537-43. doi: 10.1016/j.neuroimage.2008.06.002. Epub 2008 Jun 13.

2.

PET neuroimaging of extrastriatal dopamine receptors and prefrontal cortex functions.

Takahashi H.

J Physiol Paris. 2013 Dec;107(6):503-9. doi: 10.1016/j.jphysparis.2013.07.001. Epub 2013 Jul 12. Review.

PMID:
23851135
3.

Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review.

Wang GJ, Volkow ND, Thanos PK, Fowler JS.

J Addict Dis. 2004;23(3):39-53. Review.

PMID:
15256343
4.

Imaging dopamine's role in drug abuse and addiction.

Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F.

Neuropharmacology. 2009;56 Suppl 1:3-8. doi: 10.1016/j.neuropharm.2008.05.022. Epub 2008 Jun 3. Review.

5.

Striatocortical pathway dysfunction in addiction and obesity: differences and similarities.

Tomasi D, Volkow ND.

Crit Rev Biochem Mol Biol. 2013 Jan-Feb;48(1):1-19. doi: 10.3109/10409238.2012.735642. Epub 2012 Nov 23. Review.

6.

Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity.

Trifilieff P, Martinez D.

Neuropharmacology. 2014 Jan;76 Pt B:498-509. doi: 10.1016/j.neuropharm.2013.06.031. Epub 2013 Jul 10. Review.

7.

Neurochemical and metabolic effects of acute and chronic alcohol in the human brain: Studies with positron emission tomography.

Volkow ND, Wiers CE, Shokri-Kojori E, Tomasi D, Wang GJ, Baler R.

Neuropharmacology. 2017 Aug 1;122:175-188. doi: 10.1016/j.neuropharm.2017.01.012. Epub 2017 Jan 18. Review.

PMID:
28108358

Supplemental Content

Support Center